These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 17412738

  • 1. B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response.
    Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA.
    Ann Rheum Dis; 2007 Sep; 66(9):1259-62. PubMed ID: 17412738
    [Abstract] [Full Text] [Related]

  • 2. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, Stohl W.
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [Abstract] [Full Text] [Related]

  • 3. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.
    Lu TY, Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA.
    Arthritis Rheum; 2009 Apr 15; 61(4):482-7. PubMed ID: 19333973
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation.
    Turner-Stokes T, Lu TY, Ehrenstein MR, Giles I, Rahman A, Isenberg DA.
    Rheumatology (Oxford); 2011 Aug 15; 50(8):1401-8. PubMed ID: 21398661
    [Abstract] [Full Text] [Related]

  • 5. Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen.
    Ezeonyeji AN, Isenberg DA.
    Rheumatology (Oxford); 2012 Mar 15; 51(3):476-81. PubMed ID: 22096015
    [Abstract] [Full Text] [Related]

  • 6. Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus.
    Carter LM, Isenberg DA, Ehrenstein MR.
    Arthritis Rheum; 2013 Oct 15; 65(10):2672-9. PubMed ID: 23839909
    [Abstract] [Full Text] [Related]

  • 7. Repeated B cell depletion in treatment of refractory systemic lupus erythematosus.
    Ng KP, Leandro MJ, Edwards JC, Ehrenstein MR, Cambridge G, Isenberg DA.
    Ann Rheum Dis; 2006 Jul 15; 65(7):942-5. PubMed ID: 16269424
    [Abstract] [Full Text] [Related]

  • 8. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA.
    Rheumatology (Oxford); 2005 Dec 15; 44(12):1542-5. PubMed ID: 16188950
    [Abstract] [Full Text] [Related]

  • 9. Long-term improvement of lipid profile in patients with refractory systemic lupus erythematosus treated with B-cell depletion therapy: a retrospective observational study.
    Pego-Reigosa JM, Lu TY, Fontanillo MF, del Campo-Pérez V, Rahman A, Isenberg DA.
    Rheumatology (Oxford); 2010 Apr 15; 49(4):691-6. PubMed ID: 20047982
    [Abstract] [Full Text] [Related]

  • 10. Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response.
    Jónsdóttir T, Gunnarsson I, Risselada A, Henriksson EW, Klareskog L, van Vollenhoven RF.
    Ann Rheum Dis; 2008 Mar 15; 67(3):330-4. PubMed ID: 17827182
    [Abstract] [Full Text] [Related]

  • 11. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA, van Vollenhoven RF, Buyon J, Levy RA, Navarra SV, Cervera R, Zhong ZJ, Freimuth WW, BLISS-52 and BLISS-76 Study Groups.
    Arthritis Rheum; 2013 Aug 15; 65(8):2143-53. PubMed ID: 23754628
    [Abstract] [Full Text] [Related]

  • 12. Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study.
    Fernández-Nebro A, de la Fuente JL, Carreño L, Izquierdo MG, Tomero E, Rúa-Figueroa I, Hernández-Cruz BE, Narváez J, Ucar E, Olivé A, Zea A, Fernández-Castro M, Raya-Álvarez E, Pego-Reigosa JM, Freire M, Martínez-Taboada VM, Pérez-Venegas J, Sánchez-Atrio AI, Villa-Blanco I, Manrique-Arija S, López-Longo FJ, Carreira PE, Martínez-Pérez R, García-Vicuña R.
    Lupus; 2012 Sep 15; 21(10):1063-76. PubMed ID: 22786985
    [Abstract] [Full Text] [Related]

  • 13. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S, Benseler SM, Kirby-Allen M, Silverman ED.
    Pediatrics; 2009 Jan 15; 123(1):e159-63. PubMed ID: 19074962
    [Abstract] [Full Text] [Related]

  • 14. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles.
    Cambridge G, Leandro MJ, Teodorescu M, Manson J, Rahman A, Isenberg DA, Edwards JC.
    Arthritis Rheum; 2006 Nov 15; 54(11):3612-22. PubMed ID: 17075806
    [Abstract] [Full Text] [Related]

  • 15. Effects of rituximab on resistant SLE disease including lung involvement.
    Reynolds JA, Toescu V, Yee CS, Prabu A, Situnayake D, Gordon C.
    Lupus; 2009 Jan 15; 18(1):67-73. PubMed ID: 19074171
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response.
    Jónsdóttir T, Zickert A, Sundelin B, Henriksson EW, van Vollenhoven RF, Gunnarsson I.
    Rheumatology (Oxford); 2013 May 15; 52(5):847-55. PubMed ID: 23287364
    [Abstract] [Full Text] [Related]

  • 17. [Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment].
    Tsanian MÉ, Solov'ev SK, Torgashina AV, Aleksandrova EN, Radenska-Lopovok SG, Nikolaeva EV, Khrennikova IaB, Nasonov EL.
    Ter Arkh; 2014 May 15; 86(5):40-9. PubMed ID: 25026801
    [Abstract] [Full Text] [Related]

  • 18. B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titres.
    Ioannou Y, Lambrianides A, Cambridge G, Leandro MJ, Edwards JC, Isenberg DA.
    Ann Rheum Dis; 2008 Mar 15; 67(3):425-6. PubMed ID: 17905784
    [Abstract] [Full Text] [Related]

  • 19. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
    Smith KG, Jones RB, Burns SM, Jayne DR.
    Arthritis Rheum; 2006 Sep 15; 54(9):2970-82. PubMed ID: 16947528
    [Abstract] [Full Text] [Related]

  • 20. An open study of B lymphocyte depletion in systemic lupus erythematosus.
    Leandro MJ, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA.
    Arthritis Rheum; 2002 Oct 15; 46(10):2673-7. PubMed ID: 12384926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.